T cell tolerance based on avidity thresholds rather than complete deletion allows maintenance of maximal repertoire diversity

Journal of Immunology

Volumn 165, Issue 1, 2000, Pages 25-33

  Sandberg, Johan K ^a,e   Franksson, Lars ^a,c   Sundbäck, Jonas ^a   Michaelsson, Jakob ^a   Petersson, Max ^a,c   Achour, Adnane ^a   Wallin, Robert P A ^a   Sherman, Nicholas E ^d   Bergman, Tomas ^b   Jörnvall, Hans ^b   Hunt, Donald F ^d   Kiessling, Rolf ^a,c   Kärre, Klas ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF VIRGINIA   (United States)

^e ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELONGATION FACTOR 1ALPHA; PEPTIDE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CROSS REACTION; CYTOTOXIC T LYMPHOCYTE; GENE DELETION; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN STRUCTURE; SEQUENCE ANALYSIS; T LYMPHOCYTE;

EID: 0034235795     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.1.25     Document Type: Article

References (66)

1. + thymocytes. Nature 333:742.
2. Kappler, J. W., N. Roehm, and P. Marrack. 1987. T cell tolerance by clonal elimination in the thymus. Cell 49:273.
3. Goodnow, C. C. 1996. Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc. Natl. Acad. Sci. USA 93:2264.
4. Nossal, G. J. 1994. Negative selection of lymphocytes. Cell 76:229.
5. Brocker, T., M. Riedinger, and K. Karjalainen. 1997. Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J. Exp. Med. 185:541.
6. Matzinger, P., and S. Guerder. 1989. Does T-cell tolerance require a dedicated antigen-presenting cell? Nature 338:74.
7. Marrack, P., D. Lo, R. Brinster, R. Palmiter, L. Burkly, R. H. Flavell, and J. Kappler. 1988. The effect of thymus environment on T cell development and tolerance. Cell 53:627.
8. Sprent, J., D. Lo, E. K. Gao, and Y. Ron. 1988. T cell selection in the thymus. Immunol. Rev. 101:173.
9. Oldstone, M. B., M. Nerenberg, P. Southern, J. Price, and H. Lewicki. 1991. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 65:319.
10. Ohashi, P. S., S. Oehen, K. Buerki, H. Pircher, C. T. Ohashi, B. Odermatt, B. Malissen, R. M. Zinkernagel, and H. Hengartner. 1991. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65:305.
11. Rocha, B., C. Tanchot, and H. Von Boehmer. 1993. Clonal anergy blocks in vivo growth of mature T cells and can be reversed in the absence of antigen. J. Exp. Med. 177:1517.
12. Jenkins, M. K., and R. H. Schwartz. 1987. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J. Exp. Med. 165:302.
13. Robey, E. A., F. Ramsdell, J. W. Gordon, C. Mamalaki, D. Kioussis, H. J. Youn, P. D. Gottlieb, R. Axel, and B. J. Fowlkes. 1992. A self-reactive T cell population that is not subject to negative selection. Int. Immunol. 4:969.
14. Schonrich, G., U. Kalinke, F. Momburg, M. Malissen, A. M. Schmitt-Verhulsl, B. Malissen, G. J. Hammerling, and B. Arnold. 1991. Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction. Cell 65:293.
15. Mondino, A., A. Khoruts, and M. K. Jenkins. 1996. The anatomy of T-cell activation and tolerance. Proc. Natl. Acad. Sci. USA 93:2245.
16. Ashton-Rickardt, P. G., and S. Tonegawa. 1994. A differential-avidity model for T-cell selection. Immunol. Today 15:362.
17. Sebzda, E., S. Mariathasan, T. Ohteki, R. Jones, M. F. Bachmann, and P. S. Ohashi. 1999. Selection of the T cell repertoire. Annu. Rev. Immunol. 17: 829.
18. Bevan, M. J. 1997. In thymic selection, peptide diversity gives and takes away. Immunity 7:175.
19. Tanchot, C., F. A. Lemonnier, B. Perarnau, A. A. Freitas, and B. Rocha. 1997. Differential requirements for survival and proliferation of CD8 naive or memory T cells. Science 276:2057.
20. Markiewicz, M. A., C. Girao, J. T. Opferman, J. Sun, Q. Hu, A. A. Agulnik. C. E. Bishop, C. B. Thompson, and P. G. Ashton-Rickardt. 1998. Long-term T cell memory requires the surface expression of self-peptide/major histocompatibility complex molecules. Proc. Natl. Acad. Sci. USA 95:3065.
21. Kirberg, J., A. Berns, and H. von Boehmer. 1997. Peripheral T cell survival requires continual ligation of the T cell receptor to major histocompalibility complex-encoded molecules. J. Exp. Med. 186:1269.
22. Brocker, T. 1997. Survival of mature CD4 T lymphocytes is dependent on major histocompatibility complex class II-expressing dendritic cells. J. Exp. Med. 186: 1223.
23. + T cell specificity and compensates for loss of T cell receptor contacts with the specific peptide. J. Exp. Med. 189:883.
24. Hunt, D. F., R. A. Henderson, J. Shabanowitz, K. Sakaguchi, H. Michel, N. Sevilir, A. L. Cox, E. Appella, and V. H. Engelhard. 1992. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 255:1261.
25. Rammensee, H. G., K. Falk, and O. Rotzschke. 1993. Peptides naturally presented by MHC class I molecules. Annu. Rev. Immunol. 11:213.
26. Evavold, B. D., J. Sloan-Lancaster, K. J. Wilson, J. B. Rothbard, and P. M. Allen. 1995. Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands. Immunity 2:655.
27. Udaka, K., K. H. Wiesmuller, S. Kienle, G. Jung, and P. Walden. 1995. Decrypting the structure of major histocompatibility complex class I-restricted cytotoxic T lymphocyte epitopes with complex peptide libraries. J. Exp. Med. 181:2097.
28. Hemmer, B., M. Vergelli, B. Gran, N. Ling, P. Conlon, C. Pinilla, R. Houghten, H. F. McFarland, and R. Martin. 1998. Predictable TCR antigen recognition based on peptide scans leads to the identification of agonist ligands with no sequence homology. J. Immunol. 160:3631.
29. Hemmer, B., M. Vergelli, C. Pinilla, R. Houghten, and R. Martin. 1998. Probing degeneracy in T-cell recognition using peptide combinatorial libraries. Immunol. Today 19:163.
30. Kersh, G. J., and P. M. Allen. 1996. Structural basis for T cell recognition of altered peptide ligands: a single T cell receptor can productively recognize a large continuum of related ligands. J. Exp. Med. 184:1259.
31. Ohteki, T., A. Hessel, M. F. Bachmann, A. Zakarian, E. Sebzda, M. S. Tsao, K. McKall-Faienza, B. Odermatt, and P. S. Ohashi. 1999. Identification of a cross-reactive self ligand in virus-mediated autoimmunity. Eur. J. Immunol. 29: 2886.
32. Horwitz, M. S., Y. Yanagi, and M. B. Oldstone. 1994. T-cell receptors from virus-specific cytotoxic T lymphocytes recognizing a single immunodominant nine-amino-acid viral epitope show marked diversity. J. Virol. 68:352.
33. Cole, G. A., T. L. Hogg, and D. L. Woodland. 1994. The MHC class I-restricted T cell response to Sendai virus infection in C57BL/6 mice: a single immunodominant epitope elicits an extremely diverse repertoire of T cells. Int. Immunol. 6:1767.
34. Merrick, W. C. 1992. Mechanism and regulation of eukaryotic protein synthesis. Microbiol. Rev. 56:291.
35. Knudsen, S. M., J. Frydenberg, B. F. Clark, and H. Leffers. 1993. Tissue-dependent variation in the expression of elongation factor-1α isoforms: isolation and characterization of a cDNA encoding a novel variant of human elongation-factor 1α. Eur. J. Biochem. 215:549.
36. Lee, S., A. M. Francoeur, S. Liu, and E. Wang. 1992. Tissue-specific expression in mammalian brain, heart, and muscle of S1, a member of the elongation factor-1α gene family. J. Biol. Chem. 267:24064.
37. Hafezparast, M., and E. Fisher. 1998. Wasted by an elongation factor. Trends Genet. 14:215.
38. Ljunggren, H. G., and K. Karre. 1985. Host resistance directed selectively against H-2-deficient lymphoma variants: analysis of the mechanism. J. Exp. Med. 162: 1745.
39. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176:1693.
40. Kast, W. M., L. Roux, J. Curren, H. J. Blom, A. C. Voordouw, R. H. Meloen, D. Kolakofsky, and C. J. Melief. 1991. Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. Proc. Natl. Acad. Sci. USA 88:2283.
41. Rotzschke, O., K. Falk, S. Stevanovic, G. Jung, P. Walden, and H. G. Rammensee. 1991. Exact prediction of a natural T cell epitope. Eur. J. Immunol. 21:2891.
42. h-restricted epitopes and reversal by dendritic cell-mediated antigen delivery. J. Immunol. 160:3163.
43. h. Science 257:919.
44. Franksson, L., M. Petersson, R. Kiessling, and K. Karre. 1993. Immunization against tumor and minor histocompatibility antigens by eluted cellular peptides loaded on antigen processing defective cells. Eur. J. Immunol. 23:2606.
45. Altman, J. D., P. A. H. Moss, P. J. R. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94.
46. Achour, A., R. A. Harris, K. Persson, J. Sundback, C. L. Sentman, G. Schneider, Y. Lindqvist, and K. Karre. 1999. Murine class 1 major histocompatibility complex H-2Dd: expression, refolding and crystallization. Acta Crystallogr. D Biol. Crystallogr. 55:260.
47. Welle, S., C. Thornton, K. Bhatt, and M. Krym. 1997. Expression of elongation factor-1α and S1 in young and old human skeletal muscle. J. Gerontol. A Biol. Sci. Med. Sci. 52:B235.
48. Crawford, F., H. Kozono, J. White, P. Marrack, and J. Kappler. 1998. Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes. Immunity 8:675.
49. Sykulev, Y., M. Joo, I. Vturina, T. J. Tsomides, and H. N. Eisen. 1996. Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. Immunity 4:565.
50. Schild, H., O. Rotzschke, H. Kalbacher, and H. G. Rammensee. 1990. Limit of T cell tolerance to self proteins by peptide presentation. Science 247:1587.
51. Targoni, O. S., and P. V. Lehmann. 1998. Endogenous myelin basic protein inactivates the high avidity T cell repertoire. J. Exp. Med. 187:2055.
52. Theobald, M., J. Biggs, J. Hernandez, J. Lustgarten, C. Labadie, and L. A. Sherman. 1997. Tolerance to p53 by A2.1-restricted cytotoxic T lymphocytes. J. Exp. Med. 185:833.
53. Yule, T. D., A. Basten, and P. M. Allen. 1993. Hen egg-white lysozyme-specific T cells elicited in hen egg-white lysozyme-transgenic mice retain an imprint of self-tolerance. J. Immunol. 151:3057.
54. Liu, G. Y., P. J. Fairchild, R. M. Smith, J. R. Prowle, D. Kioussis, and D. C. Wraith. 1995. Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity 3:407.
55. Townsend, A. R., J. Rothbard, F. M. Gotch, G. Bahadur, D. Wraith, and A. J. McMichael. 1986. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44: 959.
56. Hausmann, S., M. Martin, L. Gauthier, and K. W. Wucherpfennig. 1999. Structural features of autoreactive TCR that determine the degree of degeneracy in peptide recognition. J. Immunol. 162:338.
57. Boesteanu, A., M. Brehm, L. M. Mylin, G. J. Christianson, S. S. Tevethia, D. C. Roopenian, and S. Joyce. 1998. A molecular basis for how a single TCR interfaces multiple ligands. J. Immunol. 161:4719.
58. Kawai, K., and P. S. Ohashi. 1995. Immunological function of a defined T-cell population tolerized to low-affinity self antigens. Nature 374:68.
59. Boon, T., P. G. Coulie, and B. Van den Eynde. 1997. Tumor antigens recognized by T cells. Immunol. Today 18:267.
60. Gilboa, E. 1999. The makings of a tumor rejection antigen. Immunity 11:263.
61. Wang, R., Y. Wang-Zhu, C. R. Gabaglia, K. Kimachi, and H. M. Grey. 1999. The stimulation of low-affinity, nontolerized clones by heteroclitic antigen analogues causes the breaking of tolerance established to an immunodominant T cell epitope. J. Exp. Med. 190:983.
62. Ohkouchi, K., H. Mizutani, M. Tanaka, M. Takahashi, K. Nakashima, and M. Shimizu. 1999. Anti-elongation factor-1α autoantibody in adult atopic dermatitis patients. Int. Immunol. 11:1635.
63. Shultz, L. D., H. O. Sweet, M. T. Davisson, and D. R. Coman. 1982. "Wasted," a new mutant of the mouse with abnormalities characteristic to ataxia telangiectasia. Nature 297:402.
64. Chambers, D. M., J. Peters, and C. M. Abbott. 1998. The lethal mutation of the mouse wasted (wst) is a deletion that abolishes expression of a tissue-specific isoform of translation elongation factor 1", encoded by the Eef1a2 gene. Proc. Natl. Acad Sci. USA 95:4463.
65. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245.
66. Shiina, M., Y. Gotoh, N. Kubomura, A. Iwamatsu, and E. Nishida. 1994. Microtubule severing by elongation factor 1α. Science 266:282.